http://archinte.jamanetwork.com/ en-us Sat, 01 Dec 2012 00:00:00 GMT Tue, 01 Jan 2013 00:49:55 GMT Silverchair editor@archinte.jamanetwork.com webmaster@archinte.jamanetwork.com http://archinte.jamanetwork.com/article.aspx?articleID=1368351 Mon, 26 Nov 2012 00:00:00 GMT Daskivich L, Mangione CM. <span class="paragraphSection">Diabetes, a major cause of morbidity and mortality in the United States and the leading cause of new cases of blindness in adults, affects more than 25 million people, or 8.3% of the population. Currently, only 60% of persons with diabetes receive standard-of-care screening examinations for retinopathy, and the number is even lower in the safety net. Given that the projected increase in the prevalence of diabetes will increase the demand for screening examinations, we must identify alternative ways to screen for diabetic retinopathy (DR).</span> 172 21 1678 1680 10.1001/2013.jamainternmed.406 http://archinte.jamanetwork.com/article.aspx?articleID=1368351 http://archinte.jamanetwork.com/article.aspx?articleID=1368357 Mon, 26 Nov 2012 00:00:00 GMT Garg S, Jani PD, Kshirsagar AV, et al. <span class="paragraphSection">Early detection of diabetic retinopathy (DR) is crucial to prevent blindness. Timely intervention with laser therapy can reduce the risk of severe vision loss by more than 90%. Despite well-accepted national and international guidelines, on average, less than 50% of patients with diabetes mellitus (DM) undergo screening for retinopathy in the United States. Barriers to care include socioeconomic factors, geography, lack of patient education, and cultural barriers among minorities.</span> 172 21 1677 1680 10.1001/archinternmed.2012.4372 http://archinte.jamanetwork.com/article.aspx?articleID=1368357